Clinical Trials Directory

Trials / Unknown

UnknownNCT05347420

Diagnostic Accuracy of Quantitative Neuropad Test for Diabetic Peripheral Neuropathy

Status
Unknown
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
First Affiliated Hospital of Chongqing Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aimed to evaluate the diagnostic vaule of quantitative Neuropad for diabetic peripheral neuropathy

Detailed description

This is a diagnostic study. Every patient will undertake Neuropad test, inculding the visual and quantitative screening tests. The visual screening test includes whether the Neuropad test paper changes completely from blue to pink within 10 minutes (visual screening test a) and the time to complete color change (visual screening test b). the quantitative screening test using a handheld color scanner to scan the rate of color change, which estimated by the slope of the Neuropad color change per minute. The visual and quantitative screening tests were compared when the Neuropathy Disability Score (NDS) and the Neurological Symptom Score (NSS) combined score as diagnostic criteria.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTThe visual Neuropad test and the quantitative Neuropad testThe visual screening test includes whether the Neuropad test paper changes completely from blue to pink within 10 minutes (visual screening test a) and the time to complete color change (visual screening test b). the quantitative screening test using a handheld color scanner to scan the rate of color change, which estimated by the slope of the Neuropad color change per minute.

Timeline

Start date
2020-08-01
Primary completion
2022-08-01
Completion
2023-08-01
First posted
2022-04-26
Last updated
2022-04-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05347420. Inclusion in this directory is not an endorsement.